10 Hot European Biotechs to watch in 2016

12-Jan-2016

Key points from article :

Including immuno-oncology treatments, antibody delivery, Tau-aggregation inhibitors and mRNA therapies.

Join the club to download article as PDF

Click on resource name for more details.

Company developing genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy.

Company developing drugs for chronic medical conditions relating to abnormalities of bacterial composition.

Company discovering and developing innovative therapeutic and diagnostic solutions targeting liver diseases.

French company developing solutions to reduce global and local emissions.

Biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies.

Synthetic Biology